Internal Medicine, Gastroenterology · New York, NY
NPI
1801873518
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
311 E 79th St
New York, NY, 10021
Phone (212) 996-6633
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$655K
430 prescriptions
Company payments, 2025
$523
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug James Aisenberg prescribed most often to Medicare patients was Sutab (Sod Sulf/Pot Chloride/Mag Sulf), with 58 prescriptions and refills. In total James Aisenberg wrote 430 Medicare prescriptions that cost $655K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 58 | 58 | 56 | $9,296 |
| Viberzi Eluxadoline | 56 | 58 | Under 11 | $93K |
| Omeprazole Generic | 43 | 111 | 12 | $719 |
| Famotidine Generic | 38 | 114 | 13 | $900 |
| Pantoprazole Sodium Generic | 36 | 91 | 15 | $664 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 22 | 22 | 22 | $3,818 |
| Stelara Ustekinumab | 18 | 23 | Under 11 | $480K |
| Rabeprazole Sodium Generic | 16 | 42 | Under 11 | $1,117 |
| Esomeprazole Magnesium Generic | 13 | 33 | Under 11 | $545 |
| Xifaxan Rifaximin | 12 | 12 | Under 11 | $29K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 11 | 11 | 11 | $746 |
Brand drugs: 207 claims; generic drugs: 223 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Aisenberg $523 ($523 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Scientific Affairs, LLC with $430.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.